"Mayne reported $31 million underlying earnings before interest, tax and depreciation for the first half on February 26 (five days after signing its scheme implementation deed with Cosette). It told shareholders it “expects to grow underlying EBITDA in the second half of the 2025 financial year via revenue growth and cost leverage”.While it’s a bit of a choose-your-own adventure outlook statement, it suggested at least $62 million EBITDA for the full year to June 30 and was a big upgrade to analysts’ forecasts. "
If I'm reading this correctly MYX stated it expects to grow EBITDA .... via revenue growth and cost leverage.
Assumptions were made that would equate to at least $ 62 million ... but this figure was not stated by MYX>
??
- Forums
- ASX - By Stock
- MYX
- Ann: Update on Scheme with Cosette
MYX
mayne pharma group limited
Add to My Watchlist
2.31%
!
$5.08

Ann: Update on Scheme with Cosette, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
-0.120(2.31%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.19 | $5.19 | $4.97 | $918.5K | 181.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | $5.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.08 | 6898 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | 5.050 |
2 | 10046 | 5.020 |
4 | 8072 | 5.010 |
1 | 8000 | 5.000 |
1 | 2426 | 4.990 |
Price($) | Vol. | No. |
---|---|---|
5.080 | 6898 | 1 |
5.110 | 3026 | 2 |
5.130 | 2426 | 1 |
5.150 | 2426 | 1 |
5.170 | 2891 | 2 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |